Literature DB >> 14966864

Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact.

Colin L Willis1, Christopher C Nolan, Sharon N Reith, Timothy Lister, Malcolm J W Prior, Christopher J Guerin, George Mavroudis, David E Ray.   

Abstract

Blood-brain barrier (BBB) breakdown is a feature of cerebral ischaemia, multiple sclerosis, and other neurodegenerative diseases, yet the relationship between astrocytes and the BBB integrity remains unclear. We present a simple in vivo model in which primary astrocyte loss is followed by microvascular damage, using the metabolic toxin 3-chloropropanediol (S-alpha-chlorohydrin). This model is uncomplicated by trauma, ischaemia, or primary immune involvement, permitting the study of the role of astrocytes in vascular endothelium integrity, maintenance of the BBB, and neuronal function. Male Fisher F344 rats given 3-chloropropanediol show astrocytic damage and death at 4-24 h in symmetrical brainstem and midbrain nuclear lesions, while neurons show morphological changes at 24-48 h. Fluorescent 10 kDa dextran tracers show the BBB leaking from 24 h, progressing to petechial haemorrhage after 48-72 h, with apparent repair after 6 days. BBB breakdown, but not the earlier astrocytic death, is accompanied by a delayed increase in blood flow in the inferior colliculus. An ED1 inflammatory response develops well after astrocyte loss, suggesting that inflammation may not be a factor in starting BBB breakdown. This model demonstrates that the BBB can self-repair despite the apparent absence of direct astrocytic-endothelial contact. The temporal separation of pathological events allows pharmacological intervention, and the mild reversible ataxia permits long-term survival studies of repair mechanisms. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966864     DOI: 10.1002/glia.10333

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  54 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells.

Authors:  Sangeetha Sukumari-Ramesh; Melissa D Laird; Nagendra Singh; John R Vender; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 3.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

4.  MRI characterisation of a novel rat model of focal astrocyte loss.

Authors:  M J W Prior; A M Brown; G Mavroudis; T Lister; D E Ray
Journal:  MAGMA       Date:  2004-12-10       Impact factor: 2.310

5.  Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus.

Authors:  Karin Borges; Dayna McDermott; Hasan Irier; Yoland Smith; Raymond Dingledine
Journal:  Exp Neurol       Date:  2006-06-21       Impact factor: 5.330

Review 6.  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

Authors:  Yuri Persidsky; Servio H Ramirez; James Haorah; Georgette D Kanmogne
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-06       Impact factor: 4.147

Review 7.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

8.  Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study.

Authors:  Mélanie Kuntz; Caroline Mysiorek; Olivier Pétrault; Maud Pétrault; Rustem Uzbekov; Régis Bordet; Laurence Fenart; Roméo Cecchelli; Vincent Bérézowski
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-02       Impact factor: 6.200

Review 9.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

Review 10.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.